Published by Dr. Brandon Richland, MD
Losing weight can be a challenge, and many people are searching for new tools to help them meet their goals. Semaglutide is one such medication that is quickly gaining attention for its role in weight loss. For most users, the maximum recommended dose of semaglutide for weight loss is 2.4 mg once a week; however, treatment usually starts at a lower dose that slowly increases over time to help the body adjust and reduce side effects, as explained in detail by medical professionals.
Semaglutide injection is a medication that supports weight management in people who are overweight or have obesity. It works by affecting hormones in the body and is available under several brand names.
Semaglutide is part of a group called GLP-1 receptor agonists. These drugs copy the action of a natural hormone, glucagon-like peptide-1 (GLP-1), which helps manage blood sugar. When semaglutide is taken, it increases insulin release when blood sugar is high and decreases the amount of glucagon the body makes.
A key effect of semaglutide is reducing appetite. It sends signals to the brain to make a person feel full sooner and longer. This helps people eat less and lose weight. By making it easier to control hunger, semaglutide can help with both chronic weight management and weight loss. These effects are supported by clinical trials and real-world use.
The FDA has approved semaglutide for weight loss and for managing type 2 diabetes. For weight management, it is sold as Wegovy. People qualify for Wegovy treatment if they have a BMI of 30 or higher (obesity) or 27 or higher with another weight-related problem like high blood pressure.
Semaglutide is also approved as Ozempic and Rybelsus for lowering blood sugar in diabetes, but only Wegovy is approved for chronic weight management. Each version has different dosing and instructions depending on what it is being used for.
When comparing semaglutide to other weight loss medications, one of the most closely watched alternatives is Mounjaro (tirzepatide). Both have delivered strong clinical results, but they operate through different mechanisms.
Semaglutide, marketed under brands like Wegovy and Ozempic, works by mimicking the GLP-1 hormone to regulate appetite, slow digestion, and reduce cravings. This often results in an average weight loss of about 15% when paired with lifestyle changes. It’s FDA-approved specifically for chronic weight management in patients with obesity or overweight and related health conditions.
Mounjaro, by contrast, is a dual-action medication that activates both GLP-1 and GIP receptors. This combination gives it a metabolic advantage, often leading to even greater weight loss, some studies report reductions of 20% or more.
Though primarily approved for type 2 diabetes, it’s increasingly prescribed off-label for weight loss due to these outcomes. Many patients feel fuller for longer on Mounjaro treatment, which can enhance adherence. However, it may also cause more gastrointestinal side effects compared to semaglutide, making individual tolerance an important factor when choosing between the two.
Healthcare providers usually start patients on a low semaglutide dose to help reduce side effects and let the body adjust. The goal is to slowly increase the dose over several weeks until it reaches the level shown to help with weight loss when combined with a reduced-calorie diet and more physical activity.
Most adults begin semaglutide at 0.25 mg injection once a week for the first 4 weeks. This low dose helps minimize nausea and other side effects as the body gets used to the medication. People should not expect significant weight loss during this phase because it is not the full treatment dose.
The starting dose is the same whether someone is starting because of a high body mass index or another reason. Even with a high BMI, starting low is safer and gives the best chance for the patient to continue treatment.
Then, with the guidance from your healthcare provider, your dose is moved up to 0.5 mg once weekly. After that, your dose may be increased by 0.5mg every 4 weeks up to 2 mg once weekly, depending on how you respond to the medication. Diet and exercise are usually recommended at the same time as this low starting dose.
After the beginning phase, semaglutide is increased step by step to reach a maintenance or target dose that supports more weight loss. The maintenance dose for most adults is 2.4 mg once per week. This is the dose that was used in studies to help adults with BMI in the overweight or obese range lose weight when combined with lifestyle changes.
These steps allow the dose to go up slowly so patients can avoid most side effects. Reaching the maintenance dose and staying on it is key to seeing better results, especially along with following a reduced-calorie diet and regular physical activity.
Not everyone can tolerate dose increases the same way. Some patients may need extra time before going up to the next level. If side effects are bothersome, the healthcare provider might keep the dose at the current level for more weeks or even lower it for a while.
A provider will check how a person is doing and might use tools like body mass index or weight measurements to track progress. If weight loss has stalled or side effects are too strong, adjustments are made. The dose should only go up following the schedule set by a doctor. Patients should keep eating fewer calories and stay active to get the best result while titrating or adjusting the dose.
Semaglutide can be taken as either a subcutaneous injection or an oral tablet. The dosing schedule, how to give the medicine, and what to do if a dose is missed all depend on the form being used.
Semaglutide is available as a weekly subcutaneous injection or as a daily oral tablet. The injectable options include brand names like Ozempic and Wegovy, which are used for both glycemic control and weight loss. The injectable is given under the skin, often in areas like the stomach, thigh, or upper arm. Rotating injection sites each week can help prevent skin problems.
The starting dose for weight loss injections is usually 0.25 mg once a week for 4 weeks. The dose may go up to reach a target dose, often 2.4 mg weekly for weight loss. Oral tablets, such as Rybelsus, are started at 3 mg once daily and may be increased to 7-14 mg daily as needed. Tablets should be taken on an empty stomach with water only, at least 30 minutes before any food or drink.
If a dose of semaglutide is missed, what to do next depends on the type and schedule. For subcutaneous injections, if less than five days have passed since the missed dose, the person should take it as soon as possible. If more than five days have passed, the missed dose should be skipped, and the next injection should be taken on the regular day.
For oral semaglutide, if a dose is missed, take it as soon as remembered unless it is near the time for the next dose. In that case, skip the missed dose and go back to the regular schedule. Do not take two doses at once.
Missing doses can affect glycemic control and may reduce how well the medication works for weight loss or slowing gastric emptying. Consistency is important for the best results with semaglutide.
Semaglutide drug is made for people who need help managing their weight because of health risks or conditions related to being overweight or obese. There are important health factors and special situations to consider before starting treatment.
Doctors usually suggest semaglutide for adults with a body mass index (BMI) of 30 or higher, which means they have obesity. It is also used for people who have a BMI of 27 or higher who also have weight-related health issues like type 2 diabetes, high blood pressure, or high cholesterol.
Before starting, doctors check for conditions like personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2), as semaglutide should not be used in these cases. Those who have had severe allergic reactions to semaglutide ingredients should not use it either.
People with a history of cardiovascular events may need extra monitoring, since semaglutide can cause changes in heart rate. Anyone with diabetic retinopathy should tell their doctor, as semaglutide might make this condition worse in some people.
Semaglutide is not advised during pregnancy, and anyone who is pregnant or planning to become pregnant should not use it. It is also not for children or people with type 1 diabetes. Patients with a history of pancreatitis need to talk to their doctor about the risks.
Some groups may need a different approach or close supervision, especially those taking other diabetes medicines or those with kidney or liver problems.
Semaglutide can help people lose weight, but it is important to know about its possible side effects and risks. Some reactions are common and mild, while others are rare but serious. People should pay attention to how they feel while taking this medication and report any concerns to their doctor.
Many people notice gastrointestinal symptoms soon after starting semaglutide. The most frequent issues include nausea, vomiting, diarrhea, constipation, and upset stomach. These symptoms usually happen most during the first few weeks of treatment or when the dose increases. They often become less bothersome over time.
Some people may experience mild stomach pain, bloating, or gas. Staying hydrated and eating smaller, lighter meals may help reduce discomfort. Most cases do not last long or require stopping the medication.
Rarely, semaglutide can cause serious health problems that need quick medical care. In some people, it has been linked to pancreatitis (inflammation of the pancreas), which may cause sudden, severe belly pain, vomiting, or fever. There is also a small risk of kidney injury if severe vomiting, diarrhea, or dehydration occur.
Semaglutide has a warning about thyroid C-cell tumors, including a rare type called medullary thyroid carcinoma (MTC) and possible risk of thyroid cancer in some studies. People with a family history of these cancers should tell their doctor. Other possible serious risks include gallbladder disease (such as gallstones), which may cause pain, nausea, or yellowing of the skin.
Patients with chronic kidney disease or other conditions like thyroid tumors should consult their primary care physician before beginning semaglutide injections. Those with a history of diabetic ketoacidosis or other serious complications may require immediate medical attention if symptoms arise.
Some people experience other side effects, such as dizziness or tiredness. These can make it harder to focus or do daily activities, especially at the start. There is also a risk of low blood sugar (hypoglycemia), especially if semaglutide is used with other diabetes medicines like insulin.
Allergic reactions are rare but possible. Symptoms might include rash, swelling, trouble breathing, or a fast heartbeat. Anyone who notices these warning signs should get medical help right away.
Semaglutide medication is not just used for weight loss. It also has important effects on blood sugar control and heart health, especially in people with certain medical issues.
Semaglutide was first approved to treat type 2 diabetes. It helps lower blood sugar by increasing insulin release and decreasing the amount of sugar made by the liver. Many people with type 2 diabetes use semaglutide to improve their glycemic control.
Some patients with type 2 diabetes may already take insulin. If they start using semaglutide, their doctor may adjust their insulin dose. Using both together can sometimes cause low blood sugar, so careful monitoring is needed.
Semaglutide should be used with caution in people who take insulin or other medicines that lower blood sugar. Reporting any symptoms of low blood sugar, like shakiness or dizziness, is very important.
Semaglutide shows benefits beyond blood sugar control. Studies have found that it may lower the risk of having serious cardiovascular events, such as heart attack or stroke, in people with type 2 diabetes.
Doctors have also seen that people taking semaglutide might experience a small increase in heart rate. This side effect is usually mild, but it is something to watch in people with heart problems.
While semaglutide does not replace other heart medicines, its use for weight loss or diabetes can offer extra heart protection for people at risk. Regular follow-up helps track both the benefits and any possible side effects related to the heart.
The price of semaglutide can change based on insurance, where it is bought, and if a person uses brand-name or compound versions. It’s also important to consult a healthcare professional before starting semaglutide treatment for weight loss.
Semaglutide can be expensive without insurance. The average cost can range from $900 to $1,800 per month for those paying out of pocket. Prices can be lower with private insurance, sometimes dropping to $25 to $300 monthly. For people with Medicare, the cost can also be lower, but coverage varies.
Some places offer compounded injectable semaglutide products, which is not the original brand but is mixed by a pharmacy. This option can cost about $279 per month and may be a choice for those looking to save money, but quality and insurance coverage can differ. Compounded semaglutide exact dosing and subcutaneous administration must be monitored closely by health care professionals.
Speaking with a healthcare provider is important before starting semaglutide. They help decide if it is safe based on a person’s medical history and other medicines being taken. Some people may have to try lifestyle changes like diet and exercise before getting a prescription.
A doctor can also explain possible side effects, including nausea, stomach problems, or risk of low blood sugar. Because insurance plans may have rules about who can get semaglutide, a healthcare provider can guide patients on getting approval or coverage. Regular visits and follow-ups help track weight loss progress and address any concerns.
Most adults begin with a low dose of 0.25 mg injected under the skin once a week. This dose helps the body adjust and lowers the chance of side effects. The starting dose usually lasts for four weeks before it’s increased. You must follow careful guidelines to avoid adverse events or dosing errors. Missing a scheduled dose or taking the next scheduled dose too soon can compromise treatment adherence.
Semaglutide is approved for weight loss even in people who do not have diabetes. The usual starting dose for non-diabetics is the same: 0.25 mg once weekly. Doctors will gradually raise the dose after several weeks if needed.
The highest approved dose for weight loss is 2.4 mg taken once every week. This is called the maintenance dose and is reached slowly over time to reduce side effects.
Weight loss can start within a few weeks, but most people see the biggest changes over several months. In studies, people lost an average of 9–10 pounds in the first 30 days. Half of participants lost around 15% of their body weight after longer use.
Semaglutide treatment has reshaped the conversation around obesity management, offering patients new hope in tackling weight-related conditions with real, measurable results. From the initial dose to the maximum dose of 2.4 mg weekly, patients treated with semaglutide often experience notable weight reduction, especially when paired with lifestyle changes. Studies have shown an impressive average weight loss over time, and for many, this progress plays a major role in overcoming insulin resistance and reducing their blood sugar level.
While oral medications exist, many patients find that injectable forms deliver more consistent results. Whether using oral or injectable formats, long-term success depends on consistent use, support from knowledgeable health care providers, and an understanding that weight regain is possible without continued commitment.
Each weight loss journey is unique, and for some, the weight lost with semaglutide can be life-changing when guided by the right professionals and regular follow-ups. If you’re considering semaglutide as a tool to help you achieve weight loss, speak with Richland MD Team of experts to determine if it’s right for your needs and health status.
Please note that this article is intended for informational purposes only and should not be construed as medical advice. Before making any changes to your treatments, please consult with your healthcare provider to discuss the appropriateness and safety of such changes.
Are you located in one of these Orange County (OC) / Southern California cities?
Aliso Viejo, Anaheim, Brea, Buena Park, Costa Mesa, Coto de Caza, Cypress, Dana Point, Fountain Valley, Fullerton, Garden Grove, Huntington Beach, Irvine, La Habra, La Palma, Laguna Beach, Laguna Hills, Laguna Niguel, Laguna Woods, Ladera Ranch, Lake Forest, Los Alamitos, Mission Viejo, Newport Beach, Orange, Placentia, Rancho Santa Margarita, San Clemente, San Juan Capistrano, Santa Ana, Seal Beach, Stanton, Tustin, Villa Park, Westminster, or Yorba Linda?
Plastic Surgeon Dr. Brandon Richland, MD and our Cosmetic Aesthetics Team are ready to help you look and feel your absolute best.
Elevate your confidence and self esteem levels to unfathomable new heights!
Schedule your in-person consultation in our modern and luxurious offices in either Fountain Valley, CA (Main HQ) or our Newport Beach, CA office.
Do you live outside of Southern California or short on time? For your convenience, Virtual Consultations are also available.
Our warm and engaging Team of carefully selected Aesthetics Professionals will make you feel calm, cool, collected, and right at home throughout your entire consultation and surgery process.
Schedule Your Aesthetics Consultation here, or call us directly at 949-867-4496 today.
Dr. Brandon Richland, MD is a respected Board Certified Licensed Plastic Surgeon in Orange County / Southern California specializing in cosmetic and reconstructive surgeries.
Driven by his passion for medicine, Dr. Richland obtained his Doctor of Medicine (M.D.) degree from the prestigious program at Saint Louis University (SLU) School of Medicine in 2013. His exceptional skills were recognized when he received the McGraw Hill / Lange Medical Student Academic Achievement Award, and graduated top of his class with Honors. For his undergraduate degree, he attended University of California, Los Angeles (UCLA) and graduated with Honors in 2009.
To further enhance his surgical expertise, Dr. Richland completed his Residency in Plastic Surgery at the University of California, Irvine (UCI) from 2013 to 2019 earning the Academic Achievement Award twice during this period. A total of 14 years in dedicated schooling and medical residency.
Dr. Richland is actively involved with healthcare and medical societies, as a Diplomate of the American Board of Plastic Surgery, a member of the American Society of Plastic Surgeons, American Society of Aesthetic Plastic Surgeons, and the California Society of Plastic Surgeons.
Contact Dr. Richland today by visiting RichlandMD.com, scheduling a cosmetic consultation, or by calling 949-867-4496 directly.
Cover Image Credit: GeckoPhotos / 123RF.com (Licensed). Photo Illustration by: Dr. Brandon Richland, MD.